Modeling amyloid-beta as homogeneous dodecamers and in complex with cellular prion protein.
Soluble amyloid beta (Aβ) peptide has been linked to the pathology of Alzheimer's disease. A variety of soluble oligomers have been observed to be toxic, ranging from dimers to protofibrils. No tertiary structure has been identified as a single biologically relevant form, though many models are...
Main Author: | Steven L Gallion |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3493521?pdf=render |
Similar Items
-
The cellular prion protein as a receptor for amyloid-beta oligomers
by: Rushworth, Joanne Valerie Humphrey
Published: (2012) -
Characterization on interactions between the prion protein and amyloid-beta
by: Bove-Fenderson, Erin
Published: (2017) -
Identification of novel cellular prion protein-based compounds to block the toxicity of amyloid-beta oligomers
by: Fluharty, Brian Richard
Published: (2015) -
Photocontrolled reversible self-assembly of dodecamer nitrilase
by: Qiao Yu, et al.
Published: (2017-08-01) -
Analysis of Dickerson dodecamer and several proteins using x-ray anomalous scattering
Published: ()